The investment objective is to track both the upward and downward evolution of the DAX Index ("Benchmark Index"), representative of the largest and most actively traded German companies that are listed on the Frankfurt Stock Exchange and to minimize the tracking error between the Fund’s performance and the performance of the Benchmark Index. The anticipated level of tracking error in normal market conditions is indicated in the prospectus. The Fund seeks to achieve its objective via a direct replication, by investing primarily in the securities comprising the Benchmark Index. To optimize the Benchmark Index replication, the Fund may use a sampling replication strategy, and may also engaged in secured securities lending. The potential use of these techniques is published on Lyxor’s website: www.lyxoretf.com. Updated composition of the Fund holdings is available on www.lyxoretf.com. In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the Fund, and might also be mentioned on the websites of the stock exchanges where the Fund is listed. The Fund is eligible to the French Equity Saving Scheme (PEA), and as consequence, a minimum of 75% of the Fund assets are invested in diversified equities issued in the European Union. The share currency is the Euro (EUR). Invested financial instruments: International equities. Dividend policy: the Fund's amounts available for distribution (if any) shall not be distributed to Shareholders, but reinvested. Net Asset Value: is daily calculated providing that the relevant stock exchanges are open for trading and orders can be covered. Redemptions: investors are able to redeem their shares on the primary market every valuation day before 17:00 CET and sell their shares on the secondary market at any time during trading hours on the Fund listing places.